Guidelines for the use of recombinant human erythropoietin

Haematologica. 1994 Nov-Dec;79(6):526-33.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia / diagnosis
  • Anemia / drug therapy*
  • Anemia / etiology
  • Clinical Trials as Topic / methods
  • Cost-Benefit Analysis
  • Erythropoietin / administration & dosage
  • Erythropoietin / adverse effects
  • Erythropoietin / economics
  • Erythropoietin / therapeutic use*
  • Humans
  • Iron Deficiencies
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / economics
  • Recombinant Proteins / therapeutic use
  • Splenomegaly / chemically induced

Substances

  • Recombinant Proteins
  • Erythropoietin